Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases
Sohyen Kwon1, Sang-Hyun Park2, Sora Mun3
1Department of Senior Healthcare, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.
Insights
Identifying new protein biomarkers like alpha-1 acid glycoprotein 2 can help distinguish type 1 myocardial infarction from other conditions with elevated troponin, improving patient diagnosis.
Area of Science:
- Biochemistry
- Cardiology
- Proteomics
Background:
- Accurate classification of myocardial infarction subtypes is essential for effective patient management.
- Current biomarkers, like troponin, lack specificity for myocardial infarction and cannot differentiate subtypes.
- Existing research suggests specific protein markers can distinguish myocardial infarction types.
Purpose of the Study:
- To identify novel protein markers capable of differentiating type 1 myocardial infarction from other conditions with elevated troponin.
- To validate identified markers alongside established cardiovascular disease and plaque rupture indicators.
Main Methods:
- Mass spectrometry was employed to compare protein profiles in type 1 myocardial infarction versus other troponin-elevating conditions.
- Candidate markers were identified and subsequently verified through further analysis.
Main Results:
- Alpha-1 acid glycoprotein 2, corticosteroid-binding globulin, and serotransferrin were identified as potential distinguishing markers.
- These markers, combined with clinical data (chest pain, ECG, troponin), show promise for specific type 1 myocardial infarction diagnosis.
Conclusions:
- Novel protein biomarkers can enhance the specificity of myocardial infarction diagnosis.
- The identified markers offer a potential pathway for improved classification of type 1 myocardial infarction.
Abstract:
Classifying myocardial infarction by subtype is crucial for appropriate patient management. Although troponin is currently the most commonly used biomarker, it is not a specific marker for myocardial infarction and cannot distinguish subtypes. Furthermore, previous studies have confirmed that proteins known as myocardial infarction markers could function to distinguish the type of myocardial infarction. Therefore, we identify a marker that can distinguish type 1 myocardial infarction from other diseases with elevated troponin. We used mass spectrometry to compare type 1 myocardial infarction with other conditions characterized by troponin elevation and identified new candidate markers for disease classification. We then verified these markers, along with those already known to be associated with cardiovascular disease and plaque rupture. We identified α-1 acid glycoprotein 2, corticosteroid-binding globulin, and serotransferrin as potential distinguishing markers. The presence of these markers and other parameters, such as chest pain, electrocardiogram, and troponin levels from the complementary diagnostic processes, could provide valuable information to specifically diagnose type 1 myocardial infarction.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations